GT Biopharma (GTBP) has filed a Request for Withdrawal with the U.S. Securities and Exchange Commission with respect to the withdrawal of the Company’s Registration Statement on Form S-1 that it ...

LIXTE Biotechnology Holdings, Inc. is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. LIXTE has ...

--IMUNON, Inc., a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it has filed a request for withdrawal with the Securities and Exchange ...

--LIXTE Biotechnology Holdings, Inc., a clinical stage pharmaceutical company, today announced that it has filed a request for withdrawal with the Securities and Exchange Commission of the Company ...

LAWRENCEVILLE, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it has ...